PLUS1
Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aridis Pharmaceuticals Inc | ARDS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.29 | -5.84% | 4.68 | 4.925 | 4.65 | 4.91 | 4.97 | 18:00:16 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.35 | 5.50 | 1.15 | 20.91% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 56 | 6,088 | $ 4.86 | $ 29,559 | 5,600 | 4.39 - 12.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 25 | $ 4.67 | USD |
Aridis Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 41.71M | 8.91M | $ -22.11M | 1.99 | 2.20 | 7.47M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 16.20% |
Aridis Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/13/2019 | 16:05 | PR Newswire (US) | Aridis Pharmaceuticals Announces Third Quarter 2019 Results |
| 10/11/2019 | 16:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/11/2019 | 05:30 | PR Newswire (US) | Aridis Pharmaceuticals Appoints Infectious Disease Expert.. |
| 10/03/2019 | 06:03 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 9/30/2019 | 05:30 | PR Newswire (US) | Aridis Pharmaceuticals Executes License Agreement with The.. |
| 9/27/2019 | 10:41 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 9/27/2019 | 05:45 | PR Newswire (US) | Aridis Pharmaceuticals to Present AR-105 and AR-501 (Gallium.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARDS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.95 | 5.85 | 4.40 | 4.98 | 16,422 | -0.27 | -5.45% |
| 1 Month | 5.44 | 5.85 | 4.39 | 5.03 | 7,387 | -0.76 | -13.97% |
| 3 Months | 8.29 | 8.29 | 4.39 | 5.92 | 6,492 | -3.61 | -43.55% |
| 6 Months | 8.52 | 12.40 | 4.39 | 8.61 | 8,108 | -3.84 | -45.07% |
| 1 Year | 8.80 | 12.40 | 4.39 | 8.89 | 6,070 | -4.12 | -46.82% |
| 3 Years | 13.02 | 13.85 | 4.39 | 10.75 | 8,934 | -8.34 | -64.06% |
| 5 Years | 13.02 | 13.85 | 4.39 | 10.75 | 8,934 | -8.34 | -64.06% |
Aridis Pharmaceuticals Description
| Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. |
